Works by McCarthy, Sharon


Results: 39
    1
    2
    3

    Post-Metastasis Survival of Patients with High-Risk Localized and Locally Advanced Prostate Cancer Undergoing Primary Treatment in the United States: A Retrospective Study: Post-Metastasis Survival of Patients with High-Risk Localized and Locally Advanced Prostate Cancer: Stephen J. Freedland et al

    Published in:
    Targeted Oncology, 2025, v. 20, n. 1, p. 139, doi. 10.1007/s11523-024-01113-5
    By:
    • Freedland, Stephen J.;
    • Fernandes, Luis;
    • De Solda, Francesco;
    • Buyukkaramikli, Nasuh;
    • Mundle, Suneel D.;
    • McCarthy, Sharon A.;
    • Labson, Daniel;
    • Yang, Lingfeng;
    • Pan, Feng;
    • Mir, Carmen
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

    Published in:
    2019
    By:
    • Patel, Shreyaskumar;
    • von Mehren, Margaret;
    • Reed, Damon R.;
    • Kaiser, Pamela;
    • Charlson, John;
    • Ryan, Christopher W.;
    • Rushing, Daniel;
    • Livingston, Michael;
    • Singh, Arun;
    • Seth, Rahul;
    • Forscher, Charles;
    • D'Amato, Gina;
    • Chawla, Sant P.;
    • McCarthy, Sharon;
    • Wang, George;
    • Parekh, Trilok;
    • Knoblauch, Roland;
    • Hensley, Martee L.;
    • Maki, Robert G.;
    • Demetri, George D.
    Publication type:
    journal article
    10
    11
    12
    13
    14
    15

    U.S. v. Marc Berger.

    Published in:
    CPA Journal, 2019, v. 89, n. 2, p. 66
    By:
    • McCarthy, Sharon L.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer.

    Published in:
    Prostate Cancer (20903111), 2022, p. 1, doi. 10.1155/2022/5454727
    By:
    • Aggarwal, Rahul;
    • Alumkal, Joshi J.;
    • Szmulewitz, Russell Z.;
    • Higano, Celestia S.;
    • Bryce, Alan H.;
    • Lopez-Gitlitz, Angela;
    • McCarthy, Sharon A.;
    • Miladinovic, Branko;
    • McQuarrie, Kelly;
    • Thomas, Shibu;
    • Zhang, Ke;
    • Small, Eric J.
    Publication type:
    Article
    22
    23
    24
    25
    26
    28
    29
    30

    Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 1, p. 73, doi. 10.1038/s41416-023-02492-8
    By:
    • Shen, John;
    • Chowdhury, Simon;
    • Agarwal, Neeraj;
    • Karsh, Lawrence I.;
    • Oudard, Stéphane;
    • Gartrell, Benjamin A.;
    • Feyerabend, Susan;
    • Saad, Fred;
    • Pieczonka, Christopher M.;
    • Chi, Kim N.;
    • Brookman-May, Sabine D.;
    • Rooney, Brendan;
    • Bhaumik, Amitabha;
    • McCarthy, Sharon A.;
    • Bevans, Katherine B.;
    • Mundle, Suneel D.;
    • Small, Eric J.;
    • Smith, Matthew R.;
    • Graff, Julie N.
    Publication type:
    Article
    31

    Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial.

    Published in:
    Asian Journal of Andrology, 2023, v. 25, n. 6, p. 653, doi. 10.4103/aja202320
    By:
    • Chung, Byung;
    • Huang, Jian;
    • Uemura, Hiroji;
    • Choi, Young;
    • Ye, Zhang-Qun;
    • Suzuki, Hiroyoshi;
    • Kang, Taek;
    • He, Da-Lin;
    • Joung, Jae;
    • Brookman-May, Sabine;
    • McCarthy, Sharon;
    • Bhaumik, Amitabha;
    • Singh, Anildeep;
    • Mundle, Suneel;
    • Chowdhury, Simon;
    • Agarwal, Neeraj;
    • Ye, Ding-Wei;
    • Chi, Kim;
    • Uemura, Hirotsugu
    Publication type:
    Article
    32
    33

    Tracking the randomized rollout of a Veterans Affairs opioid risk management tool: A multi-method implementation evaluation using the Consolidated Framework for Implementation Research (CFIR).

    Published in:
    Implementation Research & Practice, 2022, v. 3, n. 1, p. 1, doi. 10.1177/26334895221114665
    By:
    • McCarthy, Sharon A.;
    • Chinman, Matthew;
    • Rogal, Shari S.;
    • Klima, Gloria;
    • Hausmann, Leslie R. M.;
    • Mor, Maria K.;
    • Shah, Mala;
    • Hale, Jennifer A.;
    • Hongwei Zhang;
    • Gordon, Adam J.;
    • Gellad, Walid F.
    Publication type:
    Article
    34
    35

    Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy.

    Published in:
    BJU International, 2024, v. 134, n. 6, p. 982, doi. 10.1111/bju.16449
    By:
    • Merseburger, Axel S.;
    • Agarwal, Neeraj;
    • Bjartell, Anders;
    • Uemura, Hirotsugu;
    • Soto, Alvaro Juarez;
    • Bhaumik, Amitabha;
    • Böhm, Jürgen;
    • Tran, Nguyen;
    • Krochmann, Nils;
    • Nematian‐Samani, Mehregan;
    • Mundle, Suneel D.;
    • Brookman‐May, Sabine D.;
    • Lopez‐Gitlitz, Angela;
    • McCarthy, Sharon A.;
    • Chi, Kim;
    • Chowdhury, Simon
    Publication type:
    Article
    36

    Guest Column.

    Published in:
    Journal of Tax Practice & Procedure, 2014, v. 16, n. 4, p. 15
    By:
    • McCarthy, Sharon L.
    Publication type:
    Article
    37

    Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study

    Published in:
    International Journal of Urology, 2022, v. 29, n. 6, p. 533, doi. 10.1111/iju.14843
    By:
    • Uemura, Hirotsugu;
    • Arai, Gaku;
    • Uemura, Hiroji;
    • Suzuki, Hiroyoshi;
    • Aoyama, Junya;
    • Hatayama, Tomoyoshi;
    • Ito, Miku;
    • Lefresne, Florence;
    • McCarthy, Sharon;
    • Mundle, Suneel;
    • He, Jin;
    • Chi, Kim N
    Publication type:
    Article
    38

    Apalutamide for metastatic, castration‐sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double‐blind, placebo‐controlled phase 3 TITAN study.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 3, p. 280, doi. 10.1111/iju.14447
    By:
    • Uemura, Hirotsugu;
    • Arai, Gaku;
    • Uemura, Hiroji;
    • Suzuki, Hiroyoshi;
    • Iijima, Kazuyoshi;
    • Nishimura, Kazuo;
    • Fujii, Koji;
    • Hatayama, Tomoyoshi;
    • Aoyama, Junya;
    • Deprince, Kris;
    • Lopez‐Gitlitz, Angela;
    • McCarthy, Sharon;
    • Larsen, Julie S;
    • Li, Jinhui;
    • Chi, Kim N
    Publication type:
    Article
    39